Cellular Oncology

Article	Citations
Angiogenesis as a hallmark of solid tumors - clinical perspectives	135
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN	77
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities	76
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications	53
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma	51
A comprehensive review of SHP2 and its role in cancer	50
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities	41
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis	39
HDAC6: A unique HDAC family member as a cancer target	37
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment	37
Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma	34
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer	30
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers	30
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing	28
How VEGF-A and its splice variants affect breast cancer development – clinical implications	28
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells	28
Protein arginine methyltransferase 5: a potential cancer therapeutic target	28
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer	27
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin	27
The Duchenne muscular dystrophy gene and cancer	26
Clinical perspectives of BET inhibition in ovarian cancer	26
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy	26
Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation	24
Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis	23
Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications	23

Cancer‐associated fibroblasts secrete hypoxia‐induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway	22
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening	22
Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression	21
Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma	20
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models	20
LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway	19
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment	19
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer	19
Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress	18
Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer	18
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer	18
RETRACTED ARTICLE: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling	18
The impact of mitochondria on cancer treatment resistance	17
Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity	17
IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer	17
Long non‐coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p	17
Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor	17
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel	17
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia	16
Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach	16
The role of pyroptosis in hepatocellular carcinoma	15
In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer	15
Organoid technology for personalized pancreatic cancer therapy	15
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation	15
Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination	15
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer	15
SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α	14
UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells	14
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway	14
Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA	14
The application of patient-derived organoid in the research of lung cancer	14
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition	13
Crosstalk between long noncoding RNA and microRNA in Cancer	13
Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway	12
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma	12
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer	12
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy	12
IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression	12
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models	12
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer	12
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression	12
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets	12
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection	12
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS	12
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression	12
GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer	11
PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer	11
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer	11
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer	11
Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer	10

Soluble TGFBI aggravates the malignancy of cholangiocarcinoma through activation of the ITGB1 dependent PPARγ signalling pathway	10
The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis	10
Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma	10
Role of ELMO1 in inflammation and cancer—clinical implications	10
Cystatin F acts as a mediator of immune suppression in glioblastoma	10
Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κB	10
YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models	10
Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response	10
Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance	10
Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer	10
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis	10
MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway	9
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy	9
Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non‐transformed skeletal muscle cells	9
Spheroid-induced heterogeneity and plasticity of uveal melanoma cells	9
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma	9
Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells	9
Contribution of mechanical homeostasis to epithelial-mesenchymal transition	9
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors	9
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling	9
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma	9
Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer	9
Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition	9
H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis	9
Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway	9
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options	9
Involvement of ACACA (acetyl-CoA carboxylase α) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts	9
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis	8
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation	8
Application of circulating tumour cells to predict response to treatment in head and neck cancer	8
Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8+ T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma	8
The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth	8
RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma	8
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models	8
The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression	8
FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling	8
PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth	8
EV-miRome-wide profiling uncovers miR-320c for detecting metastatic colorectal cancer and monitoring the therapeutic response	8
ACSM3 suppresses the pathogenesis of high-grade serous ovarian carcinoma via promoting AMPK activity	8
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma	8
Glioblastoma, from disease understanding towards optimal cell-based in vitro models	8
MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer	8
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non‐medullary thyroid cancer	8
Iron metabolism in colorectal cancer: a balancing act	8
Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux	8
Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models	7
Molecular changes in adipocyte-derived stem cells during their interplay with cervical cancer cells	7
Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects	7
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities	7
Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation	7
YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m6A-mediated YWHAZ stability	7
Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors	7
Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis	7
Calcium acts as a central player in melatonin antitumor activity in sarcoma cells	7
Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization	7
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma	7
CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer	7
Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway	6
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models	6
Methionine-producing tumor micro(be) environment fuels growth of solid tumors	6
circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53	6
PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway	6
DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis	6
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells	6
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma	6
PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer	6
PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity	6
CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer	6
CEP55 3’-UTR promotes epithelial–mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p	6
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma	6
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy	6
A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis	6
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner	5
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer	5
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma	5
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth	5
Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?	5
Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition	5
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism	5
Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling	5

Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression	5
In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)	5
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer	5
Functional relationship between CFTR and RAC3 expression for maintaining cancer cell stemness in human colorectal cancer	5
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells	5
Drug combination screening as a translational approach toward an improved drug therapy for chordoma	5
RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis	5
Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer	5
SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans	5
SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma	5
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder	5
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2	5
Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer	5
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells	5
LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing	5
Targeting tumor-intrinsic PD-L1 suppresses the progression and aggressiveness of head and neck cancer by inhibiting GSK3β-dependent Snail degradation	5
Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines	5
Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer	5
Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics	5
Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination	5
Roles of NRF2 in DNA damage repair	5
Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway	5
RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma	5
TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma	5
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution	5
TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling	5
Altered iron metabolism as a target for ferroptosis induction in head and neck cancer	4
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis	4
The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells	4
Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers	4
Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer	4
Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma	4
COX2 confers bone marrow stromal cells to promoting TNFα/TNFR1β-mediated myeloma cell growth and adhesion	4
Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer	4
STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma	4
SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma	4
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia	4
Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer	4
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma	4
Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer	4
Ferritinophagy induced ferroptosis in the management of cancer	4
MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer	4
CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis	4
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function	4
Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK	4
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway	4
Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry	4
GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer	4
Circulating tumour cell isolation, analysis and clinical application	4
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer	4
miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in “driver gene-negative” non-small cell lung cancer via activating the Wnt/β-catenin signaling	4
The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis	4
TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer	3
USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination	3
Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer	3
Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma	3
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis	3
DNA 6mA demethylase ALKBH1 regulates DDX18 expression to promote proliferation of human head and neck squamous cell carcinoma	3
Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy	3
Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy	3
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting	3
Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells	3
ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures	3
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment	3
Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer	3
Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report	3
Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation	3
TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies	3
SS18-SSX drives CREB activation in synovial sarcoma	3
Omics-based molecular classifications empowering in precision oncology	3
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression	3
EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma	3
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway	3
Reciprocal FGF19-GLI2 signaling induces epithelial-to-mesenchymal transition to promote lung squamous cell carcinoma metastasis	3
Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer	3
Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer	3
Kavain ablates the radio-resistance of IDH-wildtype glioblastoma by targeting LITAF/NF-κB pathway	3
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data	3
TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner	3
Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma	3
Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity	3
Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma	3
Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations	3
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas	3
CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation	3
Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations	3
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma	3
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma	3
A m6A methyltransferase-mediated immune signature determines prognosis, immune landscape and immunotherapy efficacy in patients with lung adenocarcinoma	3
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer	3
Correction to: LINC00858 knockdown inhibits gastric cancer cell growth and induces apoptosis through reducing WNK2 promoter methylation	3
Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1	3
Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma	3